David Shang
Stock Analyst at Jefferies
(1.16)
# 3,646
Out of 4,501 analysts
14
Total ratings
30.8%
Success rate
-2.9%
Average return
Main Sectors:
Stocks Rated by David Shang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1875 BioDlink International Company Limited | Maintained: Buy | $4.40 | $3.59 | +22.56% | 1 | Jun 8, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $55.00 | $36.66 | +50.03% | 1 | Mar 31, 2026 | |
| HKG: 9860 Adicon Holdings Limited | Maintained: Buy | $7.00 | $3.92 | +78.57% | 1 | Mar 31, 2026 | |
| HKG: 1066 Shandong Weigao Group Medical Polymer Company Limited | Maintained: Buy | $5.20 → $5.50 | $3.29 | +67.17% | 2 | Mar 30, 2026 | |
| HKG: 1789 AK Medical Holdings Limited | Maintained: Buy | $5.50 → $7.50 | $5.25 | +42.86% | 2 | Mar 30, 2026 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Maintained: Buy | $35.00 → $40.00 | $25.32 | +57.98% | 4 | Mar 30, 2026 | |
| HKG: 3933 The United Laboratories International Holdings Limited | Maintained: Buy | $17.00 → $20.00 | $9.13 | +119.06% | 2 | Sep 5, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Hold | $4.60 | $8.11 | n/a | 1 | Jan 22, 2025 |
BioDlink International Company Limited
Jun 8, 2026
Maintained: Buy
Price Target: $4.40
Current: $3.59
Upside: +22.56%
Hangzhou Tigermed Consulting Co., Ltd
Mar 31, 2026
Maintained: Buy
Price Target: $55.00
Current: $36.66
Upside: +50.03%
Adicon Holdings Limited
Mar 31, 2026
Maintained: Buy
Price Target: $7.00
Current: $3.92
Upside: +78.57%
Shandong Weigao Group Medical Polymer Company Limited
Mar 30, 2026
Maintained: Buy
Price Target: $5.20 → $5.50
Current: $3.29
Upside: +67.17%
AK Medical Holdings Limited
Mar 30, 2026
Maintained: Buy
Price Target: $5.50 → $7.50
Current: $5.25
Upside: +42.86%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Mar 30, 2026
Maintained: Buy
Price Target: $35.00 → $40.00
Current: $25.32
Upside: +57.98%
The United Laboratories International Holdings Limited
Sep 5, 2025
Maintained: Buy
Price Target: $17.00 → $20.00
Current: $9.13
Upside: +119.06%
CSPC Pharmaceutical Group Limited
Jan 22, 2025
Maintained: Hold
Price Target: $4.60
Current: $8.11
Upside: n/a